Prolonged disease control with local treatments in oligo-acquired resistance to immune-checkpoint inhibitors

Detalles Bibliográficos
Autores principales: Arasanz, Hugo, Morilla, Idoia, Martínez-Aguillo, Maite, Teijeira, Lucía, Vera, Ruth, Alsina, Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2023
Materias:
Editorial Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10326770/
https://www.ncbi.nlm.nih.gov/pubmed/37425415
http://dx.doi.org/10.21037/tlcr-23-50
_version_ 1785069491005161472
author Arasanz, Hugo
Morilla, Idoia
Martínez-Aguillo, Maite
Teijeira, Lucía
Vera, Ruth
Alsina, Maria
author_facet Arasanz, Hugo
Morilla, Idoia
Martínez-Aguillo, Maite
Teijeira, Lucía
Vera, Ruth
Alsina, Maria
author_sort Arasanz, Hugo
collection PubMed
description
format Online
Article
Text
id pubmed-10326770
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher AME Publishing Company
record_format MEDLINE/PubMed
spelling pubmed-103267702023-07-08 Prolonged disease control with local treatments in oligo-acquired resistance to immune-checkpoint inhibitors Arasanz, Hugo Morilla, Idoia Martínez-Aguillo, Maite Teijeira, Lucía Vera, Ruth Alsina, Maria Transl Lung Cancer Res Editorial Commentary AME Publishing Company 2023-05-15 2023-06-30 /pmc/articles/PMC10326770/ /pubmed/37425415 http://dx.doi.org/10.21037/tlcr-23-50 Text en 2023 Translational Lung Cancer Research. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) .
spellingShingle Editorial Commentary
Arasanz, Hugo
Morilla, Idoia
Martínez-Aguillo, Maite
Teijeira, Lucía
Vera, Ruth
Alsina, Maria
Prolonged disease control with local treatments in oligo-acquired resistance to immune-checkpoint inhibitors
title Prolonged disease control with local treatments in oligo-acquired resistance to immune-checkpoint inhibitors
title_full Prolonged disease control with local treatments in oligo-acquired resistance to immune-checkpoint inhibitors
title_fullStr Prolonged disease control with local treatments in oligo-acquired resistance to immune-checkpoint inhibitors
title_full_unstemmed Prolonged disease control with local treatments in oligo-acquired resistance to immune-checkpoint inhibitors
title_short Prolonged disease control with local treatments in oligo-acquired resistance to immune-checkpoint inhibitors
title_sort prolonged disease control with local treatments in oligo-acquired resistance to immune-checkpoint inhibitors
topic Editorial Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10326770/
https://www.ncbi.nlm.nih.gov/pubmed/37425415
http://dx.doi.org/10.21037/tlcr-23-50
work_keys_str_mv AT arasanzhugo prolongeddiseasecontrolwithlocaltreatmentsinoligoacquiredresistancetoimmunecheckpointinhibitors
AT morillaidoia prolongeddiseasecontrolwithlocaltreatmentsinoligoacquiredresistancetoimmunecheckpointinhibitors
AT martinezaguillomaite prolongeddiseasecontrolwithlocaltreatmentsinoligoacquiredresistancetoimmunecheckpointinhibitors
AT teijeiralucia prolongeddiseasecontrolwithlocaltreatmentsinoligoacquiredresistancetoimmunecheckpointinhibitors
AT veraruth prolongeddiseasecontrolwithlocaltreatmentsinoligoacquiredresistancetoimmunecheckpointinhibitors
AT alsinamaria prolongeddiseasecontrolwithlocaltreatmentsinoligoacquiredresistancetoimmunecheckpointinhibitors

Ejemplares similares